You Guys are Getting Paid
Your endocannabinoid system has been regulating your mood, memory, and immune function for free this whole time while pharmaceutical companies charge you for synthetic alternatives. Further Reading CED Clinic BlogWhy Cannabis Works Evidence WatchCannabis…
Regulatory Digest: Rescheduling Marijuana and Controlled Substances
The controlled substances rescheduling 2026 marks a pivotal regulatory update enabling more rigorous clinical trials and research. This change may facilitate evidence-based guidelines for marijuana use. Clinicians should prepare for evolving policies as…
Cannabis Adolescent Psychiatric Risk Data Study Insights
This cannabis adolescent psychiatric risk data study highlights new concerns about marijuana use in teens and its association with psychiatric conditions. The developing adolescent brain is particularly vulnerable to cannabis effects, increasing risks…
Impairment Testing Problem Cannabis: Challenges & Insights
This daily digest highlights the impairment testing problem cannabis presents in clinical and policy contexts. It also covers cognitive safety and end-of-life access issues. The focus on impairment testing problem cannabis is crucial for advancing…
SA Risks Missing R40bn Hemp Industry Opportunity Without Coherent Strategy
South Africa's hemp industry opportunity is significant but at risk without a coherent strategy. Patients relying on local CBD products face supply inconsistencies due to regulatory gaps. Coordinated clinical research and policy alignment are essential…
Veterans Groups Urge Congress to Expand Psychedelic and Cannabis Access
Veterans cannabis psychedelic therapy access is increasingly recognized as vital for treatment-resistant PTSD. Veterans currently face risks seeking therapies outside the VA system. Expanding access would improve clinical supervision and continuity of…
Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead
Brazil cannabis regulatory framework updates mark a shift toward integrating medical cannabis into formal healthcare. New rules for domestic cultivation could expand access to regulated cannabis medicines. This framework emphasizes THC oversight,…
New Cannabis Group Will Help Ground Policy in Science and Patient Experience
A cannabis medicine group policy is working to ground federal discussions in science and patient experience. This approach aims to improve access to cannabinoid therapies. It ensures policies reflect both clinical evidence and real-world patient…
Natural Approaches to Managing Chronic Inflammation with Cannabinoids
The endocannabinoid system chronic inflammation interaction is a promising area for therapeutic exploration. Phytocannabinoids like CBD and THC modulate immune responses relevant to chronic inflammation. Understanding this system can guide safer, more…
Natural Neuroprotection: Exploring Non-Psychoactive Cannabinoids
Non-psychoactive cannabinoids neuroprotection offers promising avenues for neurological health. These compounds interact with the endocannabinoid system to modulate inflammation and oxidative stress. While preclinical data is strong, clinical evidence…
